why choose us

First received: August 24, 2022

Clinical Trial: A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Brief Summary: The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoid arthritis.

Read more